Exosomes in Epilepsy of Tuberous Sclerosis Complex: Carriers of Pro-Inflammatory MicroRNAs

Daniela Cukovic, Shruti Bagla, Dylan Ukasik, Paul M. Stemmer, Bhanu P. Jena, Akshata R. Naik, Sandeep Sood, Eishi Asano, Aimée F. Luat, Diane C. Chugani, Alan A. DombkowskiNon-Coding 2021 · DOI

TL;DR

This study reveals that exosomes released from epileptogenic tubers in Tuberous Sclerosis Complex (TSC) carry pro-inflammatory microRNAs that can activate immune signaling pathways. These findings suggest a novel mechanism for neuroinflammation in drug-resistant epilepsy and point towards exosomes as potential biomarkers and therapeutic targets.

What Problem Does This Paper Address?

Tuberous Sclerosis Complex (TSC) is a genetic disorder characterized by benign tumors (tubers) in various organs, including the brain. A significant portion of TSC patients experience drug-resistant epilepsy originating from these tubers. While neuroinflammation is suspected to play a role in this epilepsy, the precise molecular mechanisms remain unclear. Specifically, it's unknown why some tubers cause seizures while others don't, and how this contributes to drug resistance. This paper investigates whether exosomes, tiny vesicles involved in cell-to-cell communication, carry pro-inflammatory signals from epileptogenic TSC tubers that could drive this neuroinflammation.

Methods

The researchers employed a multi-pronged approach:

  • Exosome Isolation and Characterization: They isolated extracellular vesicles (EVs) from surgically resected TSC tubers, aiming for exosome-enriched fractions. These EVs were characterized using atomic force microscopy (AFM) for size and morphology, and liquid chromatography-mass spectrometry (LC-MS/MS) proteomics to confirm the presence of known exosome markers.
  • Small RNA Sequencing (RNA-Seq): They performed small RNA-seq on the isolated exosomes from both epileptogenic and non-epileptogenic TSC tubers to identify differences in their microRNA cargo.
  • In Vitro Cell Culture Experiments: They incubated human neuronal cells (SH-SY5Y) with exosomes from epileptogenic TSC tissue to assess the impact on gene expression. Gene expression analysis was conducted using the NanoString nCounter Neuroinflammation panel.
  • Bioinformatic Analysis: This included identifying TLR7/8-activating motifs in microRNAs, gene ontology analysis, protein-protein interaction network analysis (using STRING), and statistical analysis of gene expression data.
  • Tissue Analysis: Gene expression signatures observed in vitro were compared to expression levels in actual TSC tuber tissue samples.

Datasets

  • Human TSC Tuber Tissue: Exosomes were isolated from surgically resected epileptogenic and non-epileptogenic tubers from pediatric patients with TSC.
  • Human microRNA Database (miRbase): Used for comparative analysis of microRNA motifs.
  • NanoString nCounter Neuroinflammation Panel: A pre-designed panel of probes for 770 genes involved in inflammation, immunity, neurobiology, and metabolism, used for gene expression analysis.

Key Insights and Ideas

  • Exosomes as Inflammatory Messengers: The study strongly suggests that exosomes act as crucial mediators of neuroinflammation in TSC-related epilepsy. They don't just passively carry cargo; they actively deliver signals that can trigger immune responses.
  • MicroRNAs as TLR Ligands: A key finding is that specific microRNAs enriched in exosomes from epileptogenic tubers possess motifs that can directly activate Toll-like Receptors 7 and 8 (TLR7/8). This is a novel mechanism for initiating an inflammatory cascade.
  • The "Vicious Cycle" Hypothesis: The findings support the idea of a self-perpetuating cycle where seizures might lead to increased exosome release, which in turn drives neuroinflammation, lowering seizure thresholds and exacerbating epilepsy.
  • Convergent Signaling Pathways: The study highlights the activation of critical signaling pathways like innate immune response (TLR), inflammatory response, and PI3K/AKT, which are known to be dysregulated in neurological disorders and can influence mTOR signaling, a pathway already implicated in TSC.
  • Biomarker Potential: The unique exosomal microRNA signature and the gene expression patterns observed in vitro and in tissue suggest potential for developing novel biomarkers for drug-resistant epilepsy in TSC.

Key Results

  • Enriched Pro-inflammatory MicroRNAs: 12 microRNAs with TLR7/8 activating motifs were significantly enriched in exosomes from epileptogenic TSC tubers compared to non-epileptogenic tubers. Notable examples include miR-142-3p, miR-223-3p, and miR-21-5p.
  • Exosome-Induced Gene Expression: Incubation of SH-SY5Y cells with exosomes from epileptogenic tissue led to the induction of key pathways, including innate immune signaling, inflammatory response, and cytokine signaling.
  • Key Signaling Nodes Activated: Genes like SQSTM1 (p62) and CDKN1A (p21), which are highly connected nodes in inflammatory signaling networks, were significantly upregulated in response to epileptogenic exosomes.
  • In Vitro Signature Mirrors In Vivo: The gene expression signature induced by epileptogenic exosomes in vitro was also found to be significantly upregulated in actual epileptogenic TSC tuber tissue.

Limitations and Future Work

  • Limited Sample Size: The study acknowledges that isolating exosomes from solid tissue requires a substantial amount of tissue, and specimens from epilepsy surgery are limited, impacting the number of samples available. Future work could focus on improving EV isolation methods.
  • Cell Type Specificity: While SH-SY5Y cells are a useful neuronal model, future studies should investigate the effects of these exosomes on other cell types within the brain to fully understand the intercellular signaling.
  • Source and Destination of Exosomes: The paper suggests that subsequent studies should focus on identifying the specific cell types that secrete these altered exosomes and the cell types that take them up to gain a deeper understanding of the intercellular signaling mechanism.
  • Therapeutic Potential: The authors propose that exosomes, being stable and capable of crossing the blood-brain barrier, could serve as a means for non-invasive monitoring of seizure susceptibility and response to treatment, opening avenues for future therapeutic strategies.

Summary updated

Abstract

Exosomes are a class of small, secreted extracellular vesicles (EV) that have recently gained considerable attention for their role in normal cellular function, disease processes and potential as biomarkers. Exosomes serve as intercellular messengers and carry molecular cargo that can alter gene expression and the phenotype of recipient cells. Here, we investigated alterations of microRNA cargo in exosomes secreted by epileptogenic tissue in tuberous sclerosis complex (TSC), a multi-system genetic disorder that includes brain lesions known as tubers. Approximately 90% of TSC patients suffer from seizures that originate from tubers, and ~60% are resistant to antiseizure drugs. It is unknown why some tubers cause seizures while others do not, and the molecular basis of drug-resistant epilepsy is not well understood. It is believed that neuroinflammation is involved, and characterization of this mechanism may be key to disrupting the "vicious cycle" between seizures, neuroinflammation, and increased seizure susceptibility. We isolated exosomes from epileptogenic and non-epileptogenic TSC tubers, and we identified differences in their microRNA cargo using small RNA-seq. We identified 12 microRNAs (including miR-142-3p, miR-223-3p and miR-21-5p) that are significantly increased in epileptogenic tubers and contain nucleic acid motifs that activate toll-like receptors (TLR7/8), initiating a neuroinflammatory cascade. Exosomes from epileptogenic tissue caused induction of key pathways in cultured cells, including innate immune signaling (TLR), inflammatory response and key signaling nodes <i>SQSTM1</i> (p62) and <i>CDKN1A</i> (p21). Genes induced in vitro were also significantly upregulated in epileptogenic tissue. These results provide new evidence on the role of exosomes and non-coding RNA cargo in the neuroinflammatory cascade of epilepsy and may help advance the development of novel biomarkers and therapeutic approaches for the treatment of drug-resistant epilepsy.
BibTeX
@inproceedings{cukovic2021exosomes,
  author = {Daniela Cukovic and Shruti Bagla and Dylan Ukasik and Paul M. Stemmer and Bhanu P. Jena and Akshata R. Naik and Sandeep Sood and Eishi Asano and Aimée F. Luat and Diane C. Chugani and Alan A. Dombkowski},
  title = {{Exosomes in Epilepsy of Tuberous Sclerosis Complex: Carriers of Pro-Inflammatory MicroRNAs}},
  booktitle = {Non-Coding},
  year = {2021},
  doi = {10.3390/ncrna7030040},
}
Figure